Skip to main content
Prescription Drugs

Park Pharmacy & Compounding Center Issues Recall Due to Sterility Concerns

By August 28, 2013January 22nd, 2024No Comments

On August 27, 2013, the FDA issued a trio of recall alerts regarding compounded drugs. In one of the safety alerts, the FDA announced the voluntary recall of two lots of sterile injections by Park Pharmacy & Compounding Center.

Following a recent investigation of the Park Pharmacy & Compounding Center’s facilities in Irvine, California, the FDA expressed concerns over the reliability of laboratory methods used to assess sterility. The “sterile” injectables at issue were sold directly to consumers and to healthcare facilities by prescription during June and July of 2013 in California, Florida, New Mexico, and Indiana.

The following Park Pharmacy & Compounding Center injectable products have been recalled:

  • Methylcobalamin 5mg/mL 30mL Amber Vials
    • Lot #06132013@1
    • Exp: 12/10/2013
  • Multitrace-5 Concentrate 10mL Amber Vials
    • Lot #05212013@20
    • Exp: 11/17/2013

If you or a loved one has been affected by a compounding pharmacy product, contact us at or toll-free at 1-800-644-1734.